Will Brexit and Trump Affect Future Pharmaceutical Packaging and Labeling Regulations?

The Pharmaceutical industry is gradually coming into compliance with new regulatory requirements including the Falsified Medicines Directive (FMD) for Britain and the Drug Supply Chain Security Act (DSCSA) for the US. An important deadline coming up in November 2017 mandates that manufacturers must include product identifiers, serial numbers, lot numbers, and expiration dates in their[…]

The Importance of Quality Agreements

While using third-party contract manufacturers has become a common trend in the pharmaceutical and biotech industry, it is not without risk. The practice supposedly keeps costs down by avoiding equipment, validation, personnel and other production expenses leaving the burden of following Good Manufacturing Practices (GMPs) on the contract manufacturer, but this may not always be[…]

Cannabis Extracts Classified as Medicine in the UK

Across the pond, Cannabidiol (CBD)/Cannabis Extracts are set to be classified as a medicine within the UK. This comes after a decision by the Medicines & Healthcare products Regulatory Agency (MHRA) after reviewing claims of CBD successfully treating serious diseases. This means that products containing CBD can be legally distributed and purchased across the UK. CBD is the[…]

President Trump’s China Trade Stance Concerns Supplements Industry

Hank Schultz examined how the Dietary Supplements industry is reacting to President Donald Trump, and insiders are nervous. Donald Trump is well known for making controversial statements that might become policy, but the anti-China tone concerns many who rely on Chinese ingredients. Trump has nominated Peter Navarro, Ph.D., a Harvard-educated economist as head of the[…]

Trump Declares War on Drug Pricing – Or Did He?

This story is continually developing. If Trump his policies once more, we’ll post an update highlighting the new details. In January, President Donald Trump loudly declared that pharmaceutical companies are “getting away with murder” with what they charge the government and patients for medications. Unsurprisingly, his statement drove numerous drug stocks down and effectively put[…]

Prevagen Charged by FTC for Making False Claims

The marketers of popular brain supplement, Prevagen, have been charged with making deceptive and unsubstantiated claims regarding memory and improved cognitive improvement according to Stephen Daniells of Nutra Ingredients. Quincy Bioscience ran many national advertising campaigns claiming its Prevagen product is the answer for those looking to improve memory and cognitive function. The Federal Trade[…]

Restrictive Vape Laws Send Consumers Underground

In July of 2016, the state of Indiana passed down strict regulations for manufacturers of e-liquid products. The laws required acquisition of a license, detailed batch records, and security from production to sale. In many ways, Indiana’s e-cigarette laws mirror the regulations surrounding Cannabis – but nicotine is not a Schedule I drug. Vape shops[…]